CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net income	$ 1,992	$ 3,963
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,572	8,496
Amortization of deferred financing costs charged to interest expense	880	1,040
Stock-based compensation expense	725	1,573
Deferred taxes, net	1,530	42
Changes in operating assets and liabilities:
Accounts receivable	(1,864)	3,662
Other assets	(638)	2,187
Accounts payable and accrued liabilities	(7,927)	(6,669)
Accrued payroll	(402)	(2,038)
Other liabilities	97	(1,955)
Net cash provided by operating activities	2,965	10,301
Investing activities
Purchase of equipment and improvements	(1)	(466)
Net cash used in investing activities	(1)	(466)
Financing activities
Proceeds from revolving line of credit	117,850	161,555
Repayment of revolving line of credit	(116,008)	(157,079)
Repayments of debt obligations	(4,750)	(13,063)
Payments of deferred financing costs	(202)	0
Proceeds from issuance of common stock upon exercise of options and warrants	0	261
Payment of tax obligations resulting from net exercise of stock options	0	(1,486)
Net cash used in financing activities	(3,110)	(9,812)
Net change in cash	(146)	23
Cash - beginning of period	342	215
Cash - end of period	196	238
Supplemental disclosure of cash flow information
Cash paid during the period for interest	7,165	7,873
Cash paid during the period for income taxes	508	1,798
Common stock surrendered for the exercise of stock options	0	2,324
Lease liability recognized to acquire a right-of-use asset	$ 1,377	$ 0